Windham Venture Partners

Windham Venture Partners now trades as Windham Capital Partners. The firm invests in people solving difficult problems in healthcare, drawing on relationships spanning the pharmaceutical, medical device and digital health markets as well as major life sciences venture funds. It says it assesses prospective companies against a set of standards, including whether the team has relevant experience and is realistic about the challenges ahead, whether the company has moved beyond the concept stage, whether it addresses a large unmet need and market, and whether it has generated data demonstrating that its technology or product works. It also looks for technology that is either transformative or clearly superior to existing alternatives and free of intellectual property barriers. Co-founder Thomas Tsang, a physician, serves as chief scientific officer.